Overview

Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The main aim of the trial is to study whether a change of medication in non-responders to a two-weeks antipsychotic drug trial is more effective than continued treatment with the same antipsychotic. Hypothesis: Non-responders who are switched at 2 weeks to another antipsychotic are more frequently in symptomatic remission at week 8 than non-responders who stay on the same antipsychotic
Phase:
N/A
Details
Lead Sponsor:
Technische Universität München
Treatments:
Amisulpride
Antipsychotic Agents
Olanzapine
Sulpiride
Sultopride